» Articles » PMID: 25759905

Critical Asthma Syndrome in the ICU

Overview
Date 2015 Mar 12
PMID 25759905
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Critical asthma syndrome represents the most severe subset of asthma exacerbations, and the critical asthma syndrome is an umbrella term for life-threatening asthma, status asthmaticus, and near-fatal asthma. According to the 2007 National Asthma Education and Prevention Program guidelines, a life-threatening asthma exacerbation is marked by an inability to speak, a reduced peak expiratory flow rate of <25 % of a patient's personal best, and a failed response to frequent bronchodilator administration and intravenous steroids. Almost all critical asthma syndrome cases require emergency care, and most cases require hospitalization, often in an intensive care unit. Among asthmatics, those with the critical asthma syndrome are difficult to manage and there is little room for error. Patients with the critical asthma syndrome are prone to complications, they utilize immense resources, and they incite anxiety in many care providers. Managing this syndrome is anything but routine, and it requires attention, alacrity, and accuracy. The specific management strategies of adults with the critical asthma syndrome in the hospital with a focus on intensive care are discussed. Topics include the initial assessment for critical illness, initial ventilation management, hemodynamic issues, novel diagnostic tools and interventions, and common pitfalls. We highlight the use of critical care ultrasound, and we provide practical guidelines on how to manage deteriorating patients such as those with pneumothoraces. When standard asthma management fails, we provide experience-driven recommendations coupled with available evidence to guide the care team through advanced treatment. Though we do not discuss medications in detail, we highlight recent advances.

Citing Articles

Outcomes of children with life-threatening status asthmaticus requiring isoflurane therapy and extracorporeal life support.

Kolli S, Opolka C, Westbrook A, Gillespie S, Mason C, Truitt B J Asthma. 2023; 60(10):1926-1934.

PMID: 36927245 PMC: 10524452. DOI: 10.1080/02770903.2023.2191715.


Critical asthma syndrome in trauma patients - A case report and literature review.

Chen C, Sharma R, Singh A, Fraser D, Kilburn J Trauma Case Rep. 2022; 42:100729.

PMID: 36386429 PMC: 9647390. DOI: 10.1016/j.tcr.2022.100729.


Functional immunophenotyping of children with critical status asthmaticus identifies differential gene expression responses in neutrophils exposed to a poly(I:C) stimulus.

Grunwell J, Rad M, Stephenson S, Mohammad A, Opolka C, Fitzpatrick A Sci Rep. 2022; 12(1):19644.

PMID: 36385161 PMC: 9666940. DOI: 10.1038/s41598-022-24261-y.


The Role of Insulin Receptor Substrate Proteins in Bronchopulmonary Dysplasia and Asthma: New Potential Perspectives.

Gorgisen G, Aydin M, Mboma O, Gokyildirim M, Chao C Int J Mol Sci. 2022; 23(17).

PMID: 36077511 PMC: 9456457. DOI: 10.3390/ijms231710113.


Management of Children with Acute Asthma Attack: A RAND/UCLA Appropriateness Approach.

Fainardi V, Caffarelli C, Bergamini B, Biserna L, Bottau P, Corinaldesi E Int J Environ Res Public Health. 2021; 18(23).

PMID: 34886505 PMC: 8657661. DOI: 10.3390/ijerph182312775.


References
1.
Rodrigo G, Pollack C, Rodrigo C, Rowe B . Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev. 2006; (4):CD002884. PMC: 8407294. DOI: 10.1002/14651858.CD002884.pub2. View

2.
Barnes P . Theophylline. Am J Respir Crit Care Med. 2013; 188(8):901-6. DOI: 10.1164/rccm.201302-0388PP. View

3.
Salo D, Tuel M, Lavery R, Reischel U, Lebowitz J, Moore T . A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma. J Emerg Med. 2006; 31(4):371-6. DOI: 10.1016/j.jemermed.2006.05.025. View

4.
Adams J, Sutter M, Albertson T . The patient with asthma in the emergency department. Clin Rev Allergy Immunol. 2011; 43(1-2):14-29. DOI: 10.1007/s12016-011-8273-z. View

5.
Powell C, Dwan K, Milan S, Beasley R, Hughes R, Knopp-Sihota J . Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2012; 12:CD003898. DOI: 10.1002/14651858.CD003898.pub5. View